Role of sulfiredoxin as a peroxiredoxin-2 denitrosylase in human iPSC-derived dopaminergic neurons
Author(s) -
Carmen R. Sunico,
Abdullah Sultan,
Tomohiro Nakamura,
Nima Dolatabadi,
James Parker,
Bing Shan,
Xuemei Han,
John R. Yates,
Eliezer Masliah,
Rajesh Ambasudhan,
Nobuki Nakanishi,
Stuart A. Lipton
Publication year - 2016
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.1608784113
Subject(s) - peroxiredoxin , s nitrosylation , oxidative stress , antioxidant , dopaminergic , cysteine , regulator , chemistry , mediator , thiol , enzyme , microbiology and biotechnology , biochemistry , biology , dopamine , neuroscience , peroxidase , gene
Significance S -nitrosylation, addition of an NO group to a cysteine thiol, can regulate protein activity. Aberrant proteinS -nitrosylation, however, can disrupt normal enzyme function, as is the case forS -nitrosylated peroxiredoxin (SNO-Prx), which would otherwise catabolize toxic peroxides that occur under neurodegenerative conditions such as Parkinson’s disease. Here, we describe a paradigm ofN -phosphorylation–mediated denitrosylation by the enzyme sulfiredoxin that removes NO from Prx. The findings are at the center of redox control of the cell, explaining reactivation by sulfiredoxin of both Prx-SO2 H and SNO-Prx and thus describe a master regulator of redox reactions that combats nitrosative and oxidative stress in cells. These results suggest that sulfiredoxin may be an important target for therapeutic intervention in neurodegenerative disorders.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom